Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: Therapeutic perspective
β Scribed by P. Mazza; S. Tura; M. Bocchia; P. L. Zinzani; F. Gherlinzoni; F. Mandelli; M. P. Anselmo; G. Papa; M. Antimi; P. G. Gobbi; A. Porcellini; V. Rizzoli; L. Resegotti; A. Levis; L. Deriu; A. Chierichini; F. Ciccone; R. Fanin; G. Castoldi; G. L. Scapoli; V. Liso; T. Chisesi; L. Rancan; B. Amurri
- Book ID
- 114791368
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 287 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0902-4441
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty-two patients with non-Hodgkin's lymphoma (NHL) were treated with a combined regimen of interferon alfa-2b (Intron A; Schering-Plough) and chlorambucil to evaluate the response and efficacy in pre-treated or relapsed patients. Ten patients were classified as having follicular lymphoma and 12 d
## Abstract The follicular nonβHodgkin's lymphomas (NHL) have been among those tumors demonstrated to show frequent responses to alpha interferon in phase I and II clinical trials. In addition, there are data suggesting that alpha interferon demonstrates synergistic antitumor activity with alkylati